FDA-Drug2026-09-02Class IIMISBRANDING

Accord Healthcare levothyroxine sodium 75 mcg tablets recalled for subpotent drug

LABEL MIX UPNationwide distributionDrugs

What this means

Accord Healthcare is recalling specific lots of levothyroxine sodium 75 mcg tablets because the tablets contain less active ingredient than labeled. Levothyroxine is a thyroid hormone replacement medication, and subpotent doses may not adequately treat thyroid conditions. The affected lots are D2402016 and D2402017, expiring 08/31/2026.

  • If you take levothyroxine sodium 75 mcg tablets, check the lot number on your bottle against the recall list (D2402016 or D2402017).
  • Contact your pharmacist or doctor if you have one of the recalled lots.
  • Do not stop taking your medication without talking to your doctor first.
  • Your doctor may need to verify your dose or provide a replacement supply from a different lot.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-449-17.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0777-2026

More Accord Healthcare recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.